Envoy Medical, Inc.
COCH- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001840877
No open-market purchases or sales by Envoy Medical, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.9M in total; no superinvestor holds it.
Other share classesCOCHW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Envoy Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Envoy Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Potashnick Robert | CAO & VP of Finance | 212,500 | Aug 26, 2026 | 3 |
| Lucas Brent T. | Chief Executive Officer | 329,946 | Jun 23, 2026 | 5 |
| McKhann Chas | Director | – | Apr 17, 2026 | 1 |
| Patel Mona Chetan | Director | 332,500 | Feb 17, 2026 | 2 |
| Kantor Susan | Director | 174,037 | Feb 17, 2026 | 2 |
| Brynelsen Charles | Director | 1,050,000 | Feb 17, 2026 | 2 |
| Taylor Glen A | 10% Owner | 21,703,607 | Feb 17, 2026 | 1 |
| Smith-Gomez Janis | Director | – | Dec 5, 2025 | 1 |
| Crowe Michael Curtis | Director | – | Dec 5, 2025 | 1 |
| Anzu SPAC GP I LLC | 10% Owner | 0 | Dec 26, 2024 | 0 |
| Haring-Smith Whitney | 10% Owner | 0 | Dec 26, 2024 | 0 |
| Wells David R. | Chief Financial Officer | – | Oct 17, 2023 | 0 |
| Dewbrey Diane L | Director | 25,000 | Oct 3, 2023 | 0 |
| Huskins Priya Cherian | Director | 25,000 | Oct 3, 2023 | 0 |
| Hirsch Daniel J. | CFO and Corporate Secretary | 25,000 | Oct 3, 2023 | 0 |
| Barclays PLC | 10% Owner | – | Mar 31, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 (view filing)4:51 PM ET | Feb 12 | 5 days | Patel Mona ChetanDirector | PPurchaseClass A Common Stock | +312.5K | $0.40 | +$125.0K | +1,562.5%332.5K after | |
| Feb 17, 2026 (view filing)4:51 PM ET | Feb 12 | 5 days | Patel Mona ChetanDirector | PPurchaseClass A Common Stock | +500.0K | $0.00 | $0 | –312.5K after | Derivative2 lots |
| Feb 17, 2026 (view filing)4:49 PM ET | Feb 12 | 5 days | Potashnick RobertInterim CFO | PPurchaseClass A Common Stock | +212.5K | $0.40 | +$85.0K | New position212.5K after | |
| Feb 17, 2026 (view filing)4:49 PM ET | Feb 12 | 5 days | Potashnick RobertInterim CFO | PPurchaseClass A Common Stock | +340.0K | $0.00 | $0 | –212.5K after | Derivative2 lots |
| Feb 17, 2026 (view filing)4:47 PM ET | Feb 12 | 5 days | Kantor SusanDirector | PPurchaseClass A Common Stock | +96.2K | $0.40 | +$38.5K | +123.4%174.0K after | |
| Feb 17, 2026 (view filing)4:47 PM ET | Feb 12 | 5 days | Kantor SusanDirector | PPurchaseClass A Common Stock | +153.8K | $0.00 | $0 | –96.2K after | Derivative2 lots |
| Feb 17, 2026 (view filing)4:45 PM ET | Feb 12 | 5 days | Brynelsen CharlesDirector | PPurchaseClass A Common Stock | +1.00M | $0.40 | +$400.0K | +2,000.0%1.05M after | |
| Feb 17, 2026 (view filing)4:45 PM ET | Feb 12 | 5 days | Brynelsen CharlesDirector | PPurchaseClass A Common Stock | +1.60M | $0.00 | $0 | –1.00M after | Derivative2 lots |
| Feb 17, 2026 (view filing)4:45 PM ET | Feb 12 | 5 days | Lucas Brent T.Chief Executive Officer | PPurchaseClass A Common Stock | +62.5K | $0.40 | +$25.0K | +26.6%297.1K after | |
| Feb 17, 2026 (view filing)4:45 PM ET | Feb 12 | 5 days | Lucas Brent T.Chief Executive Officer | PPurchaseClass A Common Stock | +100.0K | $0.00 | $0 | –62.5K after | Derivative2 lots |
| Feb 17, 2026 (view filing)1:35 PM ET | Feb 12 | 5 days | Taylor Glen A10% Owner | PPurchaseClass A Common Stock | +18.8M | $0.40 | +$7.50M | +634.8%21.7M after | |
| Feb 17, 2026 (view filing)1:35 PM ET | Feb 12 | 5 days | Taylor Glen A10% Owner | PPurchaseClass A Common Stock | +30.0M | $0.00 | $0 | –18.8M after | Derivative2 lots |
| Jun 13, 2025 (view filing) | Jun 11 | 2 days | Patel Mona ChetanDirector | PPurchaseClass A Common Stock | +2.50K | $1.47 | +$3.67K | +14.3%20.0K after | |
| Jun 10, 2025 (view filing) | Jun 6 | 4 days | Patel Mona ChetanDirector | PPurchaseClass A Common Stock | +10.0K | $1.46 | +$14.6K | +133.3%17.5K after | |
| May 27, 2025 (view filing) | May 22-27 | 5 days | Brynelsen CharlesDirector | PPurchaseClass A Common Stock | +50.0K | $1.65 | +$82.4K | New position50.0K after | 3 lots |
| Dec 13, 2024 (view filing)4:10 PM ET | Dec 11 | 2 days | Lucas Brent T.Chief Executive Officer | PPurchaseClass A Common Stock | +111.0K | $0.0558 | +$6.19K | –111.0K after | Derivative2 lots |
| Nov 22, 2024 (view filing) | Nov 20 | 2 days | Patel Mona ChetanDirector | PPurchaseClass A Common Stock | +2.50K | $2.28 | +$5.70K | +50.0%7.50K after | |
| Sep 11, 2024 (view filing) | Sep 9-11 | 2 days | Patel Mona ChetanDirector | PPurchaseClass A Common Stock | +5.00K | $3.30 | +$16.5K | New position5.00K after | 2 lots |
| Mar 4, 2024 (view filing) | Feb 27 | 6 daysLate | Taylor Glen ADirector, 10% Owner | PPurchaseClass A Common Stock | +500.0K | $0.00 | $0 | –500.0K after | Derivative |
| Nov 24, 2023 (view filing) | Nov 21 | 3 days | Lucas Brent T.Chief Executive Officer | PPurchaseClass A Common Stock | +12.4K | $0.9685 | +$12.0K | +11.4%120.8K after | 2 lots |
| Oct 3, 2023 (view filing)9:58 PM ET | Sep 29 | 4 days | Haring-Smith Whitney and 1 otherDirector, 10% Owner | PPurchaseClass A Common Stock, par value $0.0001 per share | +869.6K | $11.50 | +$10.0M | –1.00M after | Derivative |